# Correction: Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis

**Authors:** Alessio Cirillo, Daniele Marinelli, Umberto Romeo, Daniela Messineo, Francesca De Felice, Marco De Vincentiis, Valentino Valentini, Silvia Mezi, Filippo Valentini, Luca Vivona, Antonella Chiavassa, Bruna Cerbelli, Daniele Santini, Paolo Bossi, Antonella Polimeni, Paolo Marchetti, Andrea Botticelli

PMC · DOI: 10.1186/s12885-024-12249-y · BMC Cancer · 2024-04-17

## Full-text entities

- **Genes:** CD274 (CD274 molecule) [NCBI Gene 29126] {aka ADMIO5, B7-H, B7H1, PD-L1, PDCD1L1, PDCD1LG1}
- **Diseases:** head and neck squamous cell carcinoma (MESH:D000077195)
- **Chemicals:** Pembrolizumab (MESH:C582435)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11022311/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11022311/full.md

## References

1 references — full list in the complete paper: https://tomesphere.com/paper/PMC11022311/full.md

---
Source: https://tomesphere.com/paper/PMC11022311